Mazda Motor (7261) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
5 Jun, 2025Executive summary
Nine-month global sales volume reached 966,000 units, up 4% year-over-year, with net sales of ¥3,689.4B, operating income of ¥148.3B, and net income of ¥90.6B.
Record high annual sales in the US and Mexico, driven by CX-50 and Large product improvements, offset declines in Japan and China.
Production and shipments of two models were temporarily suspended due to type designation test irregularities, but resumed in July after compliance confirmation.
Full-year profit forecast unchanged; global sales volume expected at 1.33M units and net sales at ¥5T.
Financial highlights
Nine-month net sales rose 3.4% year-over-year to ¥3,689.4B; operating income fell 25.9% to ¥148.3B; net income dropped 45.3% to ¥90.6B.
Third quarter net sales increased 4% year-over-year to ¥1,295.5B; operating income declined 36% to ¥45.3B.
Gross profit increased to ¥794.1B, but SG&A expenses rose to ¥645.8B.
EPS for nine months was ¥143.7, down ¥119.0 year-over-year.
Comprehensive income for the period was ¥95.6B, down from ¥215.7B year-over-year.
Outlook and guidance
Full-year forecast: net sales ¥5T (+4%), operating income ¥200B (-20%), net income ¥140B (-33%) year-over-year, EPS ¥222.10.
Global sales volume forecast at 1.33M units (+7% year-over-year), with North America up 18% and China down 20%.
Exchange rate assumptions revised to USD/JPY 153 and EUR/JPY 164; China sales forecast reduced by 20,000 units.
Latest events from Mazda Motor
- Q3 profit rebound, but full-year outlook cut amid sales declines and tariff impacts.7261
Q3 202610 Feb 2026 - Significant H1 net loss from tariffs, FX, and costs, with cautious full-year recovery outlook.7261
Q2 20267 Nov 2025 - Q1 net loss of ¥42.1B on sales decline and tariffs, with cost reforms targeting recovery.7261
Q1 20265 Aug 2025 - Profits fell despite sales growth, with North America offsetting declines elsewhere.7261
Q2 202513 Jun 2025 - Record profit growth and resumed production followed regulatory review in Q1 FY2025.7261
Q1 202513 Jun 2025 - Net income fell 45% despite record North American sales; FY2026 outlook withheld.7261
Q4 20256 Jun 2025